Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Vabbing (look it up on TikTok) is the practice of putting one’s own vaginal fluid to the body in order to attract future mates or suitors. Researchers have yet to determine whether or not human pheromones exist or how they function. Vabbing can alter a user’s psychological state, improving their perceived attractiveness. According to experts, those willing to attempt vabbing may already be the type of people capable of meeting a relationship or sexual partner.
Family Medicine/General Practice May 3rd 2023
As published in Cochrane Reviews, cranberry products reduce the risk of repeat symptomatic UTIs in women by more than a quarter. In children and individuals susceptible to UTI following medical interventions, the risk reduction is greater than 50%.
Annals of Internal Medicine
The study followed nearly 143,000 women who underwent hysterectomy for a benign condition over a 20-year-period and compared outcomes between those who had bilateral salpingo-oophorectomy (BSO) and those who didn’t. Younger (under age 45) women who had BSO had a higher 10-year cumulative risk of hospitalization for CVD. Women aged 45 to 54 with BSO had a higher 10-year risk for developing cancer. Based on the findings, the authors suggest a cautious approach to ovarian removal in postmenopausal women and recommend preserving ovaries in premenopausal women without a high risk for ovarian cancer.
Oncology News Central (ONC)
Results from the RUBY trial of dostarlimab and the GY018/Keynote-068 of pembrolizumab were presented at the 2023 SGO Annual Meeting on Women’s Cancer in March and were simultaneously published in The New England Journal of Medicine. The studies examined the efficacy and safety of the medications in all individuals and those with mismatch repair deficient (dMMR) illness. Each trial examined a separate PD-1 inhibitor, pembrolizumab or dostarlimab, in combination with chemotherapy in patients with advanced or recurrent endometrial cancer. In individuals with dMMR illness, both medications lowered the chance of disease progression or death by roughly 70%.
Oncology, Medical April 18th 2023
JAMA Network
There were significant state variations in racial and ethnic disparities in TNBC incidence in this cohort study, with Black women in Delaware, Missouri, Louisiana, and Mississippi having the highest rates among all states and racial and ethnic populations. More research is needed to identify factors contributing to the significant geographic variations in racial and ethnic disparities in TNBC incidence in order to develop effective preventive measures, and social determinants of health contribute to the geographic disparities in TNBC risk, according to the findings.
Oncology, Medical March 6th 2023
Medical Professionals Reference (MPR)
Emzahh (norethindrone tablets), the progestin-only generic equivalent of the discontinued Ortho Micronor, was approved via an abbreviated NDA.
Internal Medicine February 15th 2023